In case you missed it: August 8 to August 12


A look back at the week's top stories.

Vivjoa approved for recurrent vulvovaginal candidiasis

Oteseconazole is a treatment option for those living with a previously unmet medical need.

Essentials of vulvovaginal dermatology

Correct terms and education can help normalize the conversation for patients.

Neighborhood disadvantage and fertility rates

Residing in a socioeconomically disadvantaged neighborhood was linked to moderately decreased fecundability, according to a study published in JAMA Network Open.

Maternal mortality before and during COVID pandemic

Maternal deaths in the United States rose by a staggering 33% after the onset of the COVID-19 pandemic in March 2020, which is a significantly higher percentage than the 22% overall excess death estimate linked to the pandemic, according to a research letter published in JAMA Network Open.

Monkeypox vaccine gets emergency approval to increase vaccine supply

Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.

Related Videos
Exploring the intersection of heart health and women's health | Image Credit:
Unlocking the benefits of DHEA | Image Credit:
Unlocking the power of oxytocin | Image credit:
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit:
Deciding the best treatment for uterine fibroids | Image Credit:
Clinical pearls of pediatric dermatology | Image Credit:
Approaching inflammatory vulvovaginal diseases | Image Credit:
© 2024 MJH Life Sciences

All rights reserved.